Companies / Santa Cruz Biotechnology / TNFα (TN3-19.12) FITC
Santa Cruz Biotechnology

TNFα (TN3-19.12) FITC | Santa Cruz Biotechnology

hamster monoclonal IgG; TNFα Antibody (TN3-19.12) is an IgG Armenian hamster monoclonal TNF alpha antibody (also designated TNF alpha antibody or TNFA antibody) that detects the TNF alpha protein of m, r, rabbit origin by WB, IP and IF. TNFα Antibody (TN3-19.12) is available as both the non-conjugated anti-TNF alpha antibody form, as well as multiple conjugated forms of anti-TNF alpha antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. Tumor necrosis factor β (TNFβ), also known as lymphotoxin, is a pleiotropic cytokine. TNFα, also known as cachectin, is a smaller cytokine that binds to the same receptors, producing a vast array of effects similar to those of TNFβ. TNFβ and TNFα share 30% amino acid homology and have similar biological activities. TNFβ is produced by activated lymphocytes, including CD4+ T helper cell type 1 lymphocytes, CD8+ lymphocytes and certain B lymphoblastoid cell lines. TNFα is produced by several different cell types, which include lymphocytes, neutrophils and macrophages. TNFα and TNFβ can modulate many immune and inflammatory functions, while having the ability to inhibit tumor growth. Target tumor cells must express TNF receptors 1 and 2 to be killed, with the p55 receptor mediating the cytotoxic response.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.